ERBB2 and breast cancer: We analyzed 2293 samples from 15 studies to assess whether the abnormal APC methylation was associated with breast cancer clinicopathological characteristics, including cancer stage, cancer grade, lymph node metastasis, menopausal status, ER status, PR status and HER2 status.